| 2016-COOK-67303 | |
| There are many research methods related to rare cell identification given its importance to the early detection of rare diseases and cancer. Current research methods have specific problems, such as fluorescent tagging disrupts the chemistry of the cell, dilution methods lack accuracy, and mass tagging's minute scale of observation. Researchers at Purdue University have developed a method of analyzing rare cells and molecules using mass tags, filtration, ionization, and mass spectrometry. Through ionization, heterogeneous fluids, e.g., blood samples, can be processed for a better mass reading once the samples go through an ordinary mass spectrometer. Since it is not an additive refinement process, there is no concern for the disruption of the cell's chemical makeup. This method can determine whether there is a presence of rare cells, identify the cells, and quantify the number of cells. With all of this data, more accurate diagnoses can be made. Advantages: -Quantifiable data -No chemical alterations Potential applications: -Molecule identification -Rare disease diagnosis |
|
|
|
|
Mar 23, 2018
NATL-Patent
United States
11,531,024
Dec 20, 2022
Sep 14, 2016
NATL-Patent
Japan
6883585
May 12, 2021
Dec 6, 2022
CON-Patent
United States
(None)
(None)
Mar 26, 2018
NATL-Patent
Brazil
(None)
(None)
Mar 22, 2018
NATL-Patent
Canada
(None)
(None)
Sep 24, 2016
PCT-Patent
WO
(None)
(None)
Sep 24, 2016
NATL-Patent
China
(None)
(None)
Sep 24, 2016
NATL-Patent
South Korea
(None)
(None)
Sep 24, 2016
NATL-Patent
Europe
(None)
(None)
Sep 14, 2016
DIV-Patent
Japan
(None)
(None)
Sep 24, 2015
Provisional-Patent
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |
